Back to Article List

KenyaA Review of Regulation of Genetically Modified Organisms (GMOs)Case Study of Kenya


Dec 29, 2020

Globally, national regulation of Genetically Modified Organisms (GMOs) is largely consistent with provisions of the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity (CBD), which covers transboundary movement of Living Modified Organisms (LMOs). Kenya signed the Cartagena Protocol in 2000, ratified it in 2003, and developed the National Biotechnology Development Policy in 2006. The policy led to the enactment of the Biosafety Act No. 2 of 2009 that provides for legal, institutional, and regulatory framework for harnessing the benefits of modern biotechnology. This Act established the National Biosafety Authority (NBA). The Authority facilitates responsible research in modern biotechnology while minimizing potential risks that may be posed by GMOs to human and animal health as well as adequate protection of the environment. The Authority ensures adequate level of protection for safe transfer, handling, and use of GMOs in Kenya by establishing a transparent, science-based and predictable process for review of applications.



Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox